Effects of endocrine disruptors in the development of the female reproductive tract

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorCOSTA, Elaine Maria Frade
dc.contributor.authorSPRITZER, Poli Mara
dc.contributor.authorHOHL, Alexandre
dc.contributor.authorBACHEGA, Tania A. S. S.
dc.date.accessioned2014-09-30T15:15:21Z
dc.date.available2014-09-30T15:15:21Z
dc.date.issued2014
dc.description.abstractEnvironmental agencies have identified a growing number of environmental contaminants that have endocrine disrupting activity, and these can become a major public health problem. It is suggested that endocrine disruptors could account for the higher-than-expected increase in the prevalence of some non-communicable diseases, such as obesity, diabetes, thyroid diseases, and some cancers. Several endocrine Disrupting Chemicals (EDCs), such as pesticides, bisphenol A, phthalates, dioxins, and phytoestrogens, can interact with the female reproductive system and lead to endocrine disruption. Initially, it was assumed that EDCs exert their effects by binding to hormone receptors and transcription factors, but it is currently known that they may also alter the expression of enzymes involved in the synthesis or catabolism of steroids. Biomonitoring studies have identified these compounds in adults, children, pregnant women, and fetuses. Among the diseases of the female reproductive tract associated with EDCs exposure are the following: precocious puberty, polycystic ovary syndrome, and premature ovarian failure. The different populations of the world are exposed to a great number of chemicals through different routes of infection; despite the various available studies, there is still much doubt regarding the additive effect of a mixture of EDCs with similar mechanisms of action.
dc.description.indexMEDLINE
dc.identifier.citationARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, v.58, n.2, Special Issue, p.153-161, 2014
dc.identifier.doi10.1590/0004-2730000003031
dc.identifier.eissn1677-9487
dc.identifier.issn0004-2730
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/7941
dc.language.isoeng
dc.publisherSBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA
dc.relation.ispartofArquivos Brasileiros de Endocrinologia e Metabologia
dc.rightsopenAccess
dc.rights.holderCopyright SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA
dc.subjectEndocrine disruptors
dc.subjectfemale development
dc.subjectprecocious puberty
dc.subjectpolycystic ovary syndrome
dc.subjectpremature ovarian failure
dc.subject.otherpolycystic-ovary-syndrome
dc.subject.otherglycation end-products
dc.subject.othermenstrual-cycle characteristics
dc.subject.otherbisphenol-a exposure
dc.subject.other4-vinylcyclohexene diepoxide
dc.subject.otherinsulin-resistance
dc.subject.otherlean women
dc.subject.othermouse
dc.subject.otherchemicals
dc.subject.othermethoxychlor
dc.subject.wosEndocrinology & Metabolism
dc.titleEffects of endocrine disruptors in the development of the female reproductive tract
dc.title.alternativeEfeitos dos desreguladores endócrinos no desenvolvimento do trato reprodutivo feminino
dc.typearticle
dc.type.categoryreview
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalSPRITZER, Poli Mara:Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Dept Fisiol, Lab Endocrinol Mol,Div Endocrinol, Porto Alegre, RS, Brazil
hcfmusp.author.externalHOHL, Alexandre:Univ Fed Santa Catarina, Univ Hosp, Serv Endocrinol & Metabol, Florianopolis, SC, Brazil
hcfmusp.citation.scopus84
hcfmusp.contributor.author-fmusphcELAINE MARIA FRADE COSTA
hcfmusp.contributor.author-fmusphcTANIA APARECIDA SARTORI SANCHEZ BACHEGA
hcfmusp.description.beginpage153
hcfmusp.description.endpage161
hcfmusp.description.issue2
hcfmusp.description.issueSpecial Issue
hcfmusp.description.volume58
hcfmusp.origemWOS
hcfmusp.origem.pubmed24830592
hcfmusp.origem.scieloSCIELO:S0004-27302014000200153
hcfmusp.origem.scopus2-s2.0-84900536765
hcfmusp.origem.wosWOS:000336783400009
hcfmusp.publisher.cityRIO DE JANEIRO, RJ
hcfmusp.publisher.countryBRAZIL
hcfmusp.relation.referenceAhn HJ, 2012, MOL REPROD DEV, V79, P626, DOI 10.1002/mrd.22070
hcfmusp.relation.referenceAlonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI 10.1289/ehp.8451
hcfmusp.relation.referenceAxmon A, 2004, CHEMOSPHERE, V56, P813, DOI 10.1016/j.chemosphere.2004.03.002
hcfmusp.relation.referenceBachega TASS, 2011, ARQ BRAS ENDOCRINOL, V55, P175, DOI 10.1590/S0004-27302011000200011
hcfmusp.relation.referenceBastos AMX, 2013, ARQ BRAS ENDOCRINOL, V57, P346, DOI 10.1590/S0004-27302013000500003
hcfmusp.relation.referenceBigsby R, 1999, ENVIRON HEALTH PERSP, V107, P613, DOI 10.2307/3434553
hcfmusp.relation.referenceBrieno-Enriquez MA, 2012, MOL HUM REPROD, V18, P171, DOI 10.1093/molehr/gar074
hcfmusp.relation.referenceButtke DE, 2012, ENVIRON HEALTH PERSP, V120, P1613, DOI 10.1289/ehp.1104748
hcfmusp.relation.referenceCasals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200
hcfmusp.relation.referenceChang JW, 2010, EPIDEMIOLOGY, V21, P56, DOI 10.1097/EDE.0b013e3181c2fc6e
hcfmusp.relation.referenceChao HR, 2007, FOOD CHEM TOXICOL, V45, P259, DOI 10.1016/j.fct.2006.07.032
hcfmusp.relation.referenceChristensen Brock C, 2011, Front Genet, V2, P84, DOI 10.3389/fgene.2011.00084
hcfmusp.relation.referenceCooper AR, 2011, FERTIL STERIL, V95, P1890, DOI 10.1016/j.fertnstert.2010.01.016
hcfmusp.relation.referenceCosta EMF, 2013, PROENDOCRINO, V4
hcfmusp.relation.referenceCummings AM, 1997, CRIT REV TOXICOL, V27, P367, DOI 10.3109/10408449709089899
hcfmusp.relation.referenceDecherf S, 2011, J TOXICOL ENV HEAL B, V14, P423, DOI 10.1080/10937404.2011.578561
hcfmusp.relation.referenceDiamanti-Kandarakis E, 2008, CLIN ENDOCRINOL, V69, P634, DOI 10.1111/j.1365-2265.2008.03247.x
hcfmusp.relation.referenceDiamanti-Kandarakis E, 2009, EUR J ENDOCRINOL, V160, P847, DOI 10.1530/EJE-08-0510
hcfmusp.relation.referenceDiamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002
hcfmusp.relation.referenceEichenlaub-Ritter U, 2008, MUTAT RES-GEN TOX EN, V651, P82, DOI 10.1016/j.mrgentox.2007.10.014
hcfmusp.relation.referenceFarr SL, 2004, AM J EPIDEMIOL, V160, P1194, DOI 10.1093/aje/kwi006
hcfmusp.relation.referenceFernandez M, 2010, ENVIRON HEALTH PERSP, V118, P1217, DOI 10.1289/ehp.0901257
hcfmusp.relation.referenceFortes EM, 2007, ARQ BRAS ENDOCRINOL, V51, P500, DOI 10.1590/S0004-27302007000300021
hcfmusp.relation.referenceGaido KW, 2000, MOL PHARMACOL, V58, P852
hcfmusp.relation.referenceGUILLETTE LJ, 1994, ENVIRON HEALTH PERSP, V102, P680, DOI 10.2307/3432198
hcfmusp.relation.referenceHanioka N, 1998, ARCH TOXICOL, V72, P387, DOI 10.1007/s002040050518
hcfmusp.relation.referenceHao CJ, 2012, BIOSCIENCE REP, V32, P619, DOI 10.1042/BSR20120042
hcfmusp.relation.referenceHayes TB, 2011, J STEROID BIOCHEM, V127, P64, DOI 10.1016/j.jsbmb.2011.03.015
hcfmusp.relation.referenceHoyer PB, 2001, TOXICOL PATHOL, V29, P91, DOI 10.1080/019262301301418892
hcfmusp.relation.referenceHunt PA, 2003, CURR BIOL, V13, P546, DOI 10.1016/S0960-9822(03)00189-1
hcfmusp.relation.referenceJinno M, 2011, HUM REPROD, V26, P604, DOI 10.1093/humrep/deq388
hcfmusp.relation.referenceKandaraki E, 2011, J CLIN ENDOCR METAB, V96, pE480, DOI 10.1210/jc.2010-1658
hcfmusp.relation.referenceKappeler CJ, 2012, SYST BIOL REPROD MED, V58, P57, DOI 10.3109/19396368.2011.648820
hcfmusp.relation.referenceKirigaya A, 2009, ZOOL SCI, V26, P704, DOI 10.2108/zsj.26.704
hcfmusp.relation.referenceLiem AKD, 2000, FOOD ADDIT CONTAM, V17, P241, DOI 10.1080/026520300283324
hcfmusp.relation.referenceMARTINEZ EM, 1991, REPROD TOXICOL, V5, P139, DOI 10.1016/0890-6238(91)90042-E
hcfmusp.relation.referenceMouritsen A, 2010, INT J ANDROL, V33, P346, DOI 10.1111/j.1365-2605.2010.01051.x
hcfmusp.relation.referenceNelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697
hcfmusp.relation.referenceNewbold RR, 2004, TOXICOL APPL PHARM, V199, P142, DOI 10.1016/j.taap.2003.11.033
hcfmusp.relation.referenceNewbold RR, 2009, ENVIRON HEALTH PERSP, V117, P879, DOI 10.1289/ehp.0800045
hcfmusp.relation.referenceNikaido Y, 2004, REPROD TOXICOL, V18, P803, DOI 10.1016/j.reprotox.2004.05.002
hcfmusp.relation.referencePasquali R, 2011, CLIN ENDOCRINOL, V74, P424, DOI 10.1111/j.1365-2265.2010.03956.x
hcfmusp.relation.referencePatisaul HB, 2013, ADV EXP MED BIOL, V784, P455, DOI 10.1007/978-1-4614-6199-9_21
hcfmusp.relation.referenceRubin BS, 2006, ENDOCRINOLOGY, V147, P3681, DOI 10.1210/en.2006-0189
hcfmusp.relation.referenceSchug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007
hcfmusp.relation.referenceTakeuchi T, 2004, ENDOCR J, V51, P165, DOI 10.1507/endocrj.51.165
hcfmusp.relation.referenceUribarri J, 2006, CLIN J AM SOC NEPHRO, V1, P1293, DOI 10.2215/CJN.01270406
hcfmusp.relation.referenceZhou W, 2008, MOL CELL ENDOCRINOL, V283, P12, DOI 10.1016/j.mce.2007.10.010
hcfmusp.relation.referenceZoeller RT, 2006, ENDOCRINOLOGY, V147, P5513, DOI 10.1210/en.2006-1282
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublicationc6928e0a-cd60-4e37-8aec-ccef17a1daa9
relation.isAuthorOfPublication454278ea-86ae-4314-91bf-fc64bda534d0
relation.isAuthorOfPublication.latestForDiscoveryc6928e0a-cd60-4e37-8aec-ccef17a1daa9
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
art_COSTA_Effects_of_endocrine_disruptors_in_the_development_of_2014.PDF
Tamanho:
161.45 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/42
Artigos e Materiais de Revistas Científicas - ODS/03